These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36744036)

  • 21. [COVID-19: From a clinician's perspective.].
    Kutsuna S
    Uirusu; 2020; 70(1):37-44. PubMed ID: 33967111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
    Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
    Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds.
    Lee BU
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism and Antagonism of Bacterial-Viral Coinfection in the Upper Respiratory Tract.
    Manna S; McAuley J; Jacobson J; Nguyen CD; Ullah MA; Sebina I; Williamson V; Mulholland EK; Wijburg O; Phipps S; Satzke C
    mSphere; 2022 Feb; 7(1):e0098421. PubMed ID: 35044807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
    Nagai M; Moriyama M; Ichinohe T
    mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza Infection in Ferrets with SARS-CoV-2 Infection History.
    Vilas Boas de Melo C; Peters F; van Dijken H; Lenz S; van de Ven K; Wijsman L; Gomersbach A; Schouten T; van Kasteren PB; van den Brand J; de Jonge J
    Microbiol Spectr; 2022 Dec; 10(6):e0138622. PubMed ID: 36301107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.
    Fröberg J; Diavatopoulos DA
    Curr Opin Infect Dis; 2021 Jun; 34(3):181-186. PubMed ID: 33899752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of Sendai Virus Spread, Clearance, and Immunotherapeutic Efficacy after Hematopoietic Cell Transplant Imaged Noninvasively in Mice.
    Mostafa HH; Vogel P; Srinivasan A; Russell CJ
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamically linking influenza virus infection kinetics, lung injury, inflammation, and disease severity.
    Myers MA; Smith AP; Lane LC; Moquin DJ; Aogo R; Woolard S; Thomas P; Vogel P; Smith AM
    Elife; 2021 Jul; 10():. PubMed ID: 34282728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.
    Contini C; Enrica Gallenga C; Neri G; Maritati M; Conti P
    Med Hypotheses; 2020 Nov; 144():109876. PubMed ID: 32562915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury.
    Gralinski LE; Bankhead A; Jeng S; Menachery VD; Proll S; Belisle SE; Matzke M; Webb-Robertson BJ; Luna ML; Shukla AK; Ferris MT; Bolles M; Chang J; Aicher L; Waters KM; Smith RD; Metz TO; Law GL; Katze MG; McWeeney S; Baric RS
    mBio; 2013 Aug; 4(4):. PubMed ID: 23919993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections.
    Simonds AK; Hanak A; Chatwin M; Morrell M; Hall A; Parker KH; Siggers JH; Dickinson RJ
    Health Technol Assess; 2010 Oct; 14(46):131-172. PubMed ID: 20923611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens.
    Leung EC; Chow VC; Lee MK; Tang KP; Li DK; Lai RW
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33436456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosol Dynamics Model for Estimating the Risk from Short-Range Airborne Transmission and Inhalation of Expiratory Droplets of SARS-CoV-2.
    Dhawan S; Biswas P
    Environ Sci Technol; 2021 Jul; 55(13):8987-8999. PubMed ID: 34132519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response.
    Minne A; Louahed J; Mehauden S; Baras B; Renauld JC; Vanbever R
    Immunology; 2007 Nov; 122(3):316-25. PubMed ID: 17521369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importin-α7 is required for enhanced influenza A virus replication in the alveolar epithelium and severe lung damage in mice.
    Resa-Infante P; Thieme R; Ernst T; Arck PC; Ittrich H; Reimer R; Gabriel G
    J Virol; 2014 Jul; 88(14):8166-79. PubMed ID: 24829333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower respiratory tract delivery, airway clearance, and preclinical efficacy of inhaled GM-CSF in a postinfluenza pneumococcal pneumonia model.
    Umstead TM; Hewage EK; Mathewson M; Beaudoin S; Chroneos ZC; Wang M; Halstead ES
    Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L571-L579. PubMed ID: 31994895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.
    Clay C; Donart N; Fomukong N; Knight JB; Lei W; Price L; Hahn F; Van Westrienen J; Harrod KS
    J Virol; 2012 Apr; 86(8):4234-44. PubMed ID: 22345460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.